A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis
Latest Information Update: 03 Aug 2021
At a glance
- Drugs Suplatast tosilate (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 03 Aug 2021 New trial record